Shanghai Pharma Expects 50% Increase In Net Profits This Year
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceuticals Holding, China's second-largest drug maker, revealed before its initial public offering launch on the Hong Kong market that it expects net profits to increase by half this year